Kristin Neuman is Executive Director for Biotechnology Licensing at MPEG LA, the world’s leader in patent pool management. MPEG LA broke new ground in 2010 with the launch of Librassay® - a joint patent licensing platform for molecular diagnostics – which provided a business solution to patent access concerns prior to the Supreme Court decisions in Mayo and Myriad. Currently, Kristin leads MPEG LA’s CRISPR patent pool initiative, and manages an MPEG LA/university collaboration to develop and license a therapeutic oligonucleotide portfolio.
Prior to joining MPEG LA, Kristin spent 20 years in the private practice of law, predominantly with Proskauer Rose and Fish & Neave, where she focused on IP litigation, patent prosecution, due diligence, and business transactions in biotech, pharma, and medical devices.
Kristin received a B.A. in Biochemistry from The University of Colorado, Phi Beta Kappa. She received a J.D. from Georgetown University Law Center, and clerked for the late Honorable Roger B. Andewelt of the U.S. Court of Federal Claims.